This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Americas

  1. Imagine you need treatment for cervical precancer.
    Published: November 2019
    Type: Article
  2. The STANDARD™ G6PD has achieved provisional Expert Review Panel for Diagnostics (ERPD) approval, which enables procurement with Global Fund and Unitaid funds. Point-of-care diagnostics for G6PD deficiency play a critical role in supporting appropriate treatment of Plasmodium vivax malaria and efforts to eliminate the disease.
    Published: October 2019
    Type: Article
  3. PATH’s 2018 annual report describes our work to create a healthier, more equitable world.
    Published: September 2019
    Type: Article
  4. This year's annual report features our annual financial overview, PATH's leadership, list of PATH's funders and supporters and our accomplishments in 2018.
    Published: September 2019
    Type: Resource Page
  5. La Evaluación Prospectiva de País es una plataforma de evaluación que incorpora métodos mixtos diseñada para examinar el modelo de negocios del Fondo Mundial, sus inversiones y contribuciones para que los programas nacionales de VIH, tuberculosis y malaria tengan resultados positivos e impacto. La EPP se lleva a cabo en ocho países y genera evidencia oportuna para promover mejoras en losprogramas y acelerar el progreso hacia los objetivos estratégicos del Fondo Mundial 2017-2022.Este resumen presenta los resultados de Guatemala, así como los resultados sintetizados en los ocho países EPP en 2018.
    Published: July 2019
    Type: Resource Page
  6. The new, four-year Devices, Diagnostics, and Drugs to Address Women’s Needs Product Development Partnership (D3AWN PDP) is tapping into PATH’s deep PDP expertise to develop and introduce a portfolio of devices, diagnostics, and drugs to prevent or manage preeclampsia/eclampsia (PE/E) and PPH. The D3AWN PDP is advancing affordable, accessible, safe, and effective tools for sub-Saharan communities. Solutions include:Heat-stable FDT for PPH prevention: Sublingual oxytocin in heat-stable, fast dissolving tablet.Reusable, electricity-free infusion pump for the delivery of lifesaving nutrients, fluids, and medicines: RELI Delivery System.Uterine balloon tamponade for the management of PPH: Sinapi Ellavi Uterine Balloon Tamponade.Urinary dipstick test for improved diagnoses of PE/E: LifeAssay Diagnostics Test-it™ PrCr Urinalysis Dipstick Test
    Published: June 2019
    Type: Resource Page
  7. The Prospective Country Evaluation (PCE) is an independent evaluation of the Global Fund commissioned by the Global Fund’s Technical Evaluation Reference Group (TERG). The PCE evaluates how Global Fund policies and processes play out in country in real time and aims to provide high quality, actionable and timely information to national program implementers and Global Fund policymakers. The PCE is implemented by the Centro de Investigación Epidemiologica en Salud Sexual y Reproductiva (CIESAR) in collaboration with IHME and PATH in Guatemala.This report describes key findings from grant implementation from January–November of 2018.
    Published: March 2019
    Type: Resource Page
  8. PATH's work to improve the sexual and reproductive health of women (and men) stretches back to our inception in 1977, when we were founded to improve the quality of and accessibility to contraceptive products.
    Published: March 2019
    Type: Article
  9. The IDEA review is a global synthesis of existing evidence aimed at increasing the use of high-quality data to improve immunization coverage.The goal of the IDEA project is to identify, review, synthesize, and disseminate what works to improve the use of immunization data and why it works. In partnership with PAHO, the Health Systems Analytics team at PATH conducted a “realist” systematic review of existing research evidence to determine what are the most effective interventions to improve the use of data for immunization program and policy decision-making; and why and how these interventions produce the outcomes that they do.The IDEA review draws on nearly 550 documents including published literature, working papers, project evaluations and reports, which were distilled and prioritized by global immunization experts.
    Published: March 2019
    Type: Resource Page
  10. The IDEA review is a global synthesis of existing evidence aimed at increasing the use of high-quality data to improve immunization coverage.The goal of the IDEA project is to identify, review, synthesize, and disseminate what works to improve the use of immunization data and why it works. In partnership with PAHO, the Health Systems Analytics team at PATH conducted a “realist” systematic review of existing research evidence to determine what are the most effective interventions to improve the use of data for immunization program and policy decision-making; and why and how these interventions produce the outcomes that they do.The IDEA review draws on nearly 550 documents including published literature, working papers, project evaluations and reports, which were distilled and prioritized by global immunization experts.This précis highlights key takeaways from the full report.
    Published: March 2019
    Type: Resource Page
Load more